PRMT5 is required for human embryonic stem cell proliferation but not pluripotency

Area of Science:

• Stem cell biology
• Epigenetics
• Developmental biology

Background:

• Human pluripotent stem cells (hPSCs) are vital for studying human development and regenerative medicine.
• Mouse and human embryonic stem cells (ESCs) share pluripotency networks but have molecular differences.
• Protein arginine methyltransferase 5 (PRMT5) is essential for mouse ESC pluripotency.

Purpose of the Study:

• To investigate the role of PRMT5 in human ESC (hESC) self-renewal and pluripotency.
• To compare PRMT5 function in hESCs with its known role in mouse ESCs.

Main Methods:

• Depletion of PRMT5 in hESCs.
• Microarray analysis to assess gene expression changes.
• Assessment of pluripotency markers (OCT4, NANOG, SOX2) and teratoma formation.
• Cell cycle analysis to evaluate proliferation.

Main Results:

• PRMT5 depletion did not affect hESC pluripotency markers or teratoma formation.
• Microarray analysis showed minimal gene expression changes upon PRMT5 depletion (78 genes).
• PRMT5 regulates hESC proliferation by controlling G1 phase progression and upregulating the cell cycle inhibitor P57.

Conclusions:

• PRMT5 has a distinct role in hESCs, primarily regulating proliferation rather than pluripotency.
• P57 is identified as a novel target of PRMT5 in hESCs.